Helocyte Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.22M

  • Investors
  • 4

Helocyte General Information

Description

Developer of immunotherapies designed for the treatment and prevention of cancer and infectious diseases. The company focuses on innovative therapies targeting cytomegalovirus, incorporating advanced research methodologies, enabling healthcare providers to offer improved treatment options while addressing significant unmet medical needs in oncology and infectious disease management.

Contact Information

Website
helocyte.com
Formerly Known As
DiaVax Biosciences, Helocyte Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Gansevoort Street
  • 9th Floor
  • New York, NY 10014
  • United States
+1 (212)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2 Gansevoort Street
  • 9th Floor
  • New York, NY 10014
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Helocyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 15-Jun-2023 $3.22M Completed Clinical Trials - Phase 2
3. Grant 11-Aug-2022 Completed Startup
2. Early Stage VC 03-Nov-2016 $4M $4M Completed Startup
1. Grant 01-Nov-2015 Completed Startup
To view Helocyte’s complete valuation and funding history, request access »

Helocyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Helocyte Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute Of Allergy and Infectious Diseases Government
Fortress Biotech Corporation Minority
SternAegis Ventures Corporate Venture Capital Minority
National Cancer Institute Government
To view Helocyte’s complete investors history, request access »

Ready to get started?

Request a free trial

Helocyte FAQs

  • When was Helocyte founded?

    Helocyte was founded in 2015.

  • Where is Helocyte headquartered?

    Helocyte is headquartered in New York, NY.

  • What is the size of Helocyte?

    Helocyte has 2 total employees.

  • What industry is Helocyte in?

    Helocyte’s primary industry is Biotechnology.

  • Is Helocyte a private or public company?

    Helocyte is a Private company.

  • What is Helocyte’s current revenue?

    The current revenue for Helocyte is .

  • How much funding has Helocyte raised over time?

    Helocyte has raised $4M.

  • Who are Helocyte’s investors?

    National Institute Of Allergy and Infectious Diseases, Fortress Biotech, SternAegis Ventures, and National Cancer Institute have invested in Helocyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process